The article discusses Gocovri, a medication used to manage Parkinson’s disease symptoms, available in three capsule strengths: 68.5 mg, 137 mg, and 204 mg. It is typically prescribed as a once-daily dose taken at bedtime to enhance efficacy and …
The article discusses Fanapt, an oral medication used to treat schizophrenia, available in various strengths ranging from 1 mg to 20 mg. The typical starting dose for adults is 2 mg twice daily, which can be adjusted based on individual response and …
Fanapt, or iloperidone, is an atypical antipsychotic primarily used to treat schizophrenia and sometimes bipolar disorder. It works by blocking dopamine D2 and serotonin 5-HT2A receptors, helping to restore neurotransmitter balance and alleviate …
The article outlines dosage guidelines for Neupro, a medication used for Parkinson’s disease and restless legs syndrome. It starts at 2 mg/24 hours for Parkinson’s and 1 mg/24 hours for restless legs, with a maximum of 24 mg/24 hours. Patients …
Neupro (rotigotine) is a transdermal patch that treats Parkinson’s disease and restless legs syndrome (RLS) by acting as a dopamine agonist, mimicking dopamine’s effects in the brain. It provides a steady medication release over 24 hours, …
Nuplazid (pimavanserin) is an FDA-approved medication specifically designed to treat Parkinson’s disease psychosis (PDP), which includes hallucinations and delusions. It is significant in Parkinson’s treatment as it uniquely targets …
Duopa is a groundbreaking treatment for Parkinson’s disease (PD), designed to manage motor symptoms through a continuous infusion of carbidopa and levodopa, two medications that work together to replenish dopamine levels in the brain. …
Stalevo is a combination medication essential for managing Parkinson’s Disease (PD), containing levodopa, carbidopa, and entacapone. It increases dopamine levels in the brain, addressing symptoms like tremors and rigidity due to the …
Apokyn, or apomorphine, is an essential treatment for Parkinson’s Disease (PD), particularly for managing motor fluctuations and “off” episodes in patients not fully responding to standard therapies. As a dopamine agonist, it …
Inbrija, an inhaled formulation of levodopa, offers a significant advancement in managing Parkinson’s disease, particularly during “off” periods when traditional oral medications are ineffective. Approved by the FDA in 2018, Inbrija …
Rytary is an FDA-approved medication for managing symptoms of Parkinson’s Disease (PD) and certain forms of parkinsonism. It combines carbidopa and levodopa in an extended-release formulation, allowing for a gradual release of levodopa, which …
Inbrija is an inhalation powder approved by the FDA in 2018 for managing “off” times in Parkinson’s disease patients, offering rapid relief through the inhalation of levodopa, which converts to dopamine in the brain. It is not a …
